05.02 - Monitoring airway disease最新文献_第7页

Clinical consequences of health measures and lock down for covid-19 in exacerbations in patients with chronic obstructive pulmonary disease (COPD) 卫生措施和covid-19封锁对慢性阻塞性肺疾病(COPD)患者病情加重的临床影响

05.02 - Monitoring airway disease Pub Date : 2022-09-04 DOI: 10.1183/13993003.congress-2022.1386

C. Manzano, L. Alcarraz, A. Moncusi, S. Santisteve, J. González, F. Barbé

{"title":"Clinical consequences of health measures and lock down for covid-19 in exacerbations in patients with chronic obstructive pulmonary disease (COPD)","authors":"C. Manzano, L. Alcarraz, A. Moncusi, S. Santisteve, J. González, F. Barbé","doi":"10.1183/13993003.congress-2022.1386","DOIUrl":"https://doi.org/10.1183/13993003.congress-2022.1386","url":null,"abstract":"Introduction: Covid-19 pandemic has meant that measures such as social distance, self protection measures and lock down can have an impact on exacerbations in patients with COPD. The aim of our study is to evaluate the impact about these measures on exacerbations in COPD patients. Material(s) and Method(s): Retrospective observational study of COPD patients visited at two public hospitals in Lleida in 2019. Several clinical variables and the number and type of exacerbations from March 2019 to December 2021 were collected from their electronic history. The mean number of exacerbations from March to May 2020 (period of lock down) was analyzed and compared with the same period of the previous year (March-May 2019). The behavior of exacerbations after progressive ending of lock down period (June 2020-December 2021) was observed. Result(s): A total of 310 patients were included with a mean (SD) age of 66.8+/-8.34 years. Patients had a FEV1 of 48.5+/-18.8% and 19.7% of them belong to group D according to GOLD guidelines. In lock down period between March and May 2020 there was a reduction in the mean number of exacerbations compared to the same period of the previous year (0.13+/-0.34 vs. 0.36+/-0.55;p<0.001). An increase in exacerbations was observed in the subsequent periods from June 2020 to February 2021 (0.3+/-0.56) and from June 2021 to December 2021 (0.43+/-0.68), coinciding with the relaxation of health measures. Conclusion(s): The results of our study suggest that measures such as lock down, social distance and self-protection have an impact on exacerbations in patients with COPD.","PeriodicalId":414532,"journal":{"name":"05.02 - Monitoring airway disease","volume":"34 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"114114903","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Do particles in exhaled air samples differ between asthmatic and non-asthmatic adults? 哮喘和非哮喘的成年人呼出的空气样本中的颗粒不同吗?

05.02 - Monitoring airway disease Pub Date : 2022-09-04 DOI: 10.1183/13993003.congress-2022.3071

L. Healy, F. Al-Huda, E. Barrett, L. Willmore, R. Tudge, G. Kerry, C. Murray, A. Simpson, S. Fowler, S. Drake, R. Wang

引用次数: 0

Airflow obstruction as a marker of prognosis in rheumatoid arthritis 气流阻塞作为类风湿关节炎预后的标志

05.02 - Monitoring airway disease Pub Date : 2022-09-04 DOI: 10.1183/13993003.congress-2022.2411

A. Denis, C. Régnier, M. Henket, N. Maes, M. Thys, R. Louis, M. Malaise, J. Guiot

引用次数: 0

Effects of menopause and fat mass in asthmatic inflammation in female asthmatics 绝经期和脂肪量对女性哮喘患者哮喘性炎症的影响

05.02 - Monitoring airway disease Pub Date : 2022-09-04 DOI: 10.1183/13993003.congress-2022.3569

A. Papaioannou, A. Papaporfyriou, M. Kallieri, E. Papachatzopoulou, P. Giouleka, G. Papadaki, A. Spathis, P. Bakakos, S. Papiris, S. Loukides

引用次数: 0

Health status, activity score and dyspnoea grade in chronic bronchitis, COPD and healthy controls in China 中国慢性支气管炎、慢性阻塞性肺病和健康对照者的健康状况、活动评分和呼吸困难等级

05.02 - Monitoring airway disease Pub Date : 2022-09-04 DOI: 10.1183/13993003.congress-2022.4552

P. Jones, R. Chen, J. Zheng, Y. Sun, F. Wen, Q. Ma, X. Li, L. Zhang, W. Ke, S. Cao, S. Hu, J. Song, C. Compton, N. Zhong

引用次数: 0

Impact of COVID-19 on hospital admissions, health status and behavioral changes of patients with severe COPD COVID-19对重症COPD患者入院、健康状况和行为改变的影响

05.02 - Monitoring airway disease Pub Date : 2022-09-04 DOI: 10.1183/13993003.congress-2022.3222

E. Pappe, R. Hammerich, J. Saccomanno, L. Erdmann, T. Sgarbossa, M. Witzenrath, N. Suttorp, R. Hübner

引用次数: 0

Familiarity and use of ERN-LUNG centres for the management of Alpha 1 Antitrypsin Deficiency 熟悉和使用ERN-LUNG中心管理α 1抗胰蛋白酶缺乏症

05.02 - Monitoring airway disease Pub Date : 2022-09-04 DOI: 10.1183/13993003.congress-2022.1089

J. Chorostowska-Wynimko, A. Koczulla, M. Sucena

引用次数: 0

Evaluation of bronchial hyperreactivity in patients after Covid-19 infection Covid-19感染后支气管高反应性的评价

05.02 - Monitoring airway disease Pub Date : 2022-09-04 DOI: 10.1183/13993003.congress-2022.338

G. Strazda, M. Ieviņa, O. Madaja, N. Jurka, V. Gordjušina, I. Taivāns

引用次数: 1

RISK OF IN-HOSPITAL MORTALITY DUE TO COVID-19 IN PATIENTS WITH BRONCHIAL ASTHMA: APPLICATION OF 4C MORTALITY SCALE. 支气管哮喘患者新冠肺炎住院死亡风险分析:4c死亡率量表的应用

05.02 - Monitoring airway disease Pub Date : 2022-09-04 DOI: 10.1183/13993003.congress-2022.1170

I. M. Dominguez Zabaleta, G. Manzanares Cavi, W. I. Girón Matute, Z. Ji, B. Recio Moreno, P. Benedetti, A. Oliva Ramos, L. Puente Maestu, J. de Miguel Díez

引用次数: 0

Infectious exacerbation of asthma 哮喘的感染性加重

05.02 - Monitoring airway disease Pub Date : 2022-09-04 DOI: 10.1183/13993003.congress-2022.3252

H. Arfaoui, S. Msika, H. Jabri, W. El Khattabi, H. Afif

引用次数: 0